92 related articles for article (PubMed ID: 9623359)
1. Antiphospholipid antibodies in inflammatory bowel diseases.
Martinović Z; Perisić K; Pejnović N; Lukacević S; Rabrenović L; Petrović M
Vojnosanit Pregl; 1998; 55(2 Suppl):47-9. PubMed ID: 9623359
[TBL] [Abstract][Full Text] [Related]
2. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
3. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity, inflammatory bowel disease and hyposplenism.
Ryan FP; Ward AM; Holdsworth CD
Q J Med; 1991 Jan; 78(285):59-63. PubMed ID: 1670065
[TBL] [Abstract][Full Text] [Related]
5. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G
Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic abnormalities in inflammatory bowel disease.
Chiarantini E; Valanzano R; Liotta AA; Cellai AP; Fedi S; Ilari I; Prisco D; Tonelli F; Abbate R
Thromb Res; 1996 Apr; 82(2):137-46. PubMed ID: 9163067
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence and role of anticardiolipin antibodies in Crohn disease].
Lonjon I; Beaugerie L; Deschamps A; Barthet C; Carbonnel F; Ngô Y; Cosnes J; Abuaf N; Gendre JP
Gastroenterol Clin Biol; 1996; 20(8-9):633-7. PubMed ID: 8977809
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.
Colombel JF; Reumaux D; Duthilleul P; Noël LH; Gower-Rousseau C; Paris JC; Cortot A
Gastroenterol Clin Biol; 1992; 16(8-9):656-60. PubMed ID: 1426820
[TBL] [Abstract][Full Text] [Related]
9. Cerebral venous thrombosis in inflammatory bowel diseases: eight cases and literature review.
Cognat E; Crassard I; Denier C; Vahedi K; Bousser MG
Int J Stroke; 2011 Dec; 6(6):487-92. PubMed ID: 22017824
[TBL] [Abstract][Full Text] [Related]
10. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
Folwaczny C; Wiebecke B; Loeschke K
Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
[TBL] [Abstract][Full Text] [Related]
11. [The eye and chronic inflammatory diseases of the intestines. Immunopathological and genetic aspects. Apropos of 3 cases].
Raby O; Salvanet-Bouccara A; Forestier F
J Fr Ophtalmol; 1987; 10(11):683-98. PubMed ID: 3329203
[TBL] [Abstract][Full Text] [Related]
12. Erythema multiforme in association with active ulcerative colitis and Crohn's disease.
Chapman RS; Forsyth A; MacQueen A
Dermatologica; 1977; 154(1):32-8. PubMed ID: 844639
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
[TBL] [Abstract][Full Text] [Related]
14. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of ulcerative colitis and Crohn's disease in Turkey.
Ozin Y; Kilic MZ; Nadir I; Cakal B; Disibeyaz S; Arhan M; Dagli U; Tunc B; Ulker A; Sahin B
J Gastrointestin Liver Dis; 2009 Jun; 18(2):157-62. PubMed ID: 19565044
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: diagnostic tool or research procedure?
Andreani ML; Frascà G; Brusco G; Borgnino L; Biagi F; Gasbarrini G; Corazza GR
Ann Ital Med Int; 1996; 11(4):254-7. PubMed ID: 9050283
[TBL] [Abstract][Full Text] [Related]
17. Alterations in serum anti-alpha-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis.
D'Alessandro M; Mariani P; Lomanto D; Bachetoni A; Speranza V
Clin Immunol; 2002 Apr; 103(1):63-8. PubMed ID: 11987986
[TBL] [Abstract][Full Text] [Related]
18. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718
[TBL] [Abstract][Full Text] [Related]
19. [Serodiagnosis of Crohn's disease].
Auer IO; Wensinck F; Röder A; Merwe JP; Schmidt H; Schuster S
Dtsch Med Wochenschr; 1983 Aug; 108(33):1242-6. PubMed ID: 6872878
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
Kull K; Salupere R; Uibo R; Ots M; Salupere V
Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
